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An 82-year-old female with right chest pain was referred toour hospital. She was diagnosed with adenocarcinoma of
the lung with pleural dissemination and bone metastases. She
was treated with oral gefitinib (250 mg once daily). At first,
there was no apparent adverse event except for mild diarrhea.
Two months after the first administration of gefitinib, she
presented with mild abdominal pain, with the computed
tomography revealing extensive intramural air within the
intestinal wall, extending from the duodenum to the ascend-
ing colon, without portal venous air (Figure 1). A physical
examination indicated no sign of toxicity, with the condition
being presumed as pneumatosis cystoides intestinalis (PCI).
Gefitinib was stopped and careful monitoring with dietary
restriction was done. The symptoms gradually improved by
conservative therapy and a follow-up computed tomography
showed no sign of intramural air. Although gefitinib was
readministered, the same episode repeated three times during
gefitinib therapy.
PCI is a rare condition that is characterized by
intramural gas in the gastrointestinal tract, and its patho-
genesis is unknown.1,2 Although various chemotherapeutic
agents have been reported to be associated with PCI, there
have been no reports that addressed the association be-
tween PCI and gefitinib.
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FIGURE 1. Computed tomography at first onset of pneu-
matosis cystoides intestinalis demonstrating pneumatosis ex-
tending from the duodenum to the ascending colon.
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